Clinical Trial Update: Immunotoxin in Treating Patients With Leukemia or Lymphoma [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update describing an immunotoxin used to treat leukemia or lymphoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Immunotoxin

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED